Hematology News and Research

RSS

Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

Complex procedure offers relief for children with chronic pancreatitis

Acute recurrent pancreatitis or chronic pancreatitis can take an enormous toll on children, causing severe pain and repeated hospitalizations.

9 Nov 2026

DNA methylation patterns predict treatment response in MDS patients

DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine.

9 Nov 2026

Tai Chi and exercise may improve sleep in older cancer survivors

There is an hour of the night that belongs to no one. The house has gone still, the furnace has stopped ticking, and a man who beat cancer some years ago lies on his back, counting nothing in particular. He is not alone.

6 Nov 2026

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, USA, December 12–15, 2026.

6 Nov 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.

5 Nov 2026

ASH establishes new blood reference ranges for Duffy-null individuals

ASH has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts that affects more than 66% of people with African or Mediterranean ancestry in the US.

5 Nov 2026

New hormone receptor strategy offers targeted treatment for lupus

Researchers at the University of California, Riverside and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues.

2 Nov 2026

Terumo Blood and Cell Technologies and Ribeirão Preto Blood Center automate blood processing in Brazil

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions, announced the adoption of multiple Reveos™ Automated Blood Processing Systems by Ribeirão Preto Blood Center, the high-volume blood network supporting about 120,000 transfusions a year in São Paulo.

27 Oct 2026

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

Results from a phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers.

13 Oct 2026

New iron deficiency guidelines raise key blood test cutoffs

ASH 2026 guidelines redefine iron deficiency diagnosis with higher ferritin thresholds, aiming for better detection and management across diverse populations.

9 Oct 2026

Single tRNA controls prostate cancer identity and treatment resistance

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.

7 Oct 2026

UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries

Dr. Dennis Slamon, a pioneering oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has been awarded the 2026 Albany Prize for discoveries that transformed the understanding and treatment of cancer.

6 Oct 2026

New BCR analysis method tracks immune recovery after stem cell transplantation

A research team led by Associate Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, and Professor Hironobu Minami of the Division of Medical Oncology/Hematology at Kobe University Hospital, together with Associate Professor Goh Ohji of the Division of Infectious Disease Therapeutics and Takaji Matsutani of Anymics Inc., has developed the pGen-SHM plot.

5 Oct 2026

UC researcher receives funding to study bone complications in people with sickle cell disease

September is National Sickle Cell Awareness Month, and a University of Cincinnati College of Medicine hematology researcher has received new grant funding to study one of the disease's painful, under-recognized complications: bone damage.

25 Sep 2026

NCI awards $3.46 million grant to study resistance to acute myeloid leukemia treatment

A five-year, $3.46 million grant from the National Cancer Institute recently was awarded to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the University of California San Francisco (UCSF).

23 Sep 2026

Daily vitamin C may benefit pre-cancerous blood disorder patients

Vitamin C is an essential nutrient that supports immune function, promotes wound healing and protects cells from molecular damage.

21 Sep 2026

Diaceutics launches Precision for All Strategic Collaboration at Fierce Pharma Week 2026

Intelligence and engagement company, Diaceutics, is bringing together senior voices from across the biopharmaceutical industry at the Precision for All Strategic Collaboration, launching at Fierce Pharma Week 2026.

From Diaceutics PLC 18 Sep 2026

Shortages of crucial cancer medications continue to impact US healthcare

Today, the National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-published updated data on the current impact of generic cancer medication shortages in the United States.

10 Sep 2026

Patients' responses to oncologists can help predict survival in chronic lymphocytic leukemia

Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published in the journal Therapeutic Advances in Hematology.

7 Sep 2026

Alcohol-linked cancer deaths doubled over three decades in America

Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, a new study found. The study also revealed that alcohol-linked cancer deaths are not limited to older adults or liver cancer.

2 Sep 2026

Hematology News and Research

Further Reading

Complex procedure offers relief for children with chronic pancreatitis

DNA methylation patterns predict treatment response in MDS patients

Tai Chi and exercise may improve sleep in older cancer survivors

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

ASH establishes new blood reference ranges for Duffy-null individuals

New hormone receptor strategy offers targeted treatment for lupus

Terumo Blood and Cell Technologies and Ribeirão Preto Blood Center automate blood processing in Brazil

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

New iron deficiency guidelines raise key blood test cutoffs

Single tRNA controls prostate cancer identity and treatment resistance

UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries

New BCR analysis method tracks immune recovery after stem cell transplantation

UC researcher receives funding to study bone complications in people with sickle cell disease

NCI awards $3.46 million grant to study resistance to acute myeloid leukemia treatment

Daily vitamin C may benefit pre-cancerous blood disorder patients

Diaceutics launches Precision for All Strategic Collaboration at Fierce Pharma Week 2026

Shortages of crucial cancer medications continue to impact US healthcare

Patients' responses to oncologists can help predict survival in chronic lymphocytic leukemia

Alcohol-linked cancer deaths doubled over three decades in America

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy